Specific mutated genes began to be identified in the blood of cancer patients in the form of ctDNA about 20 years ago, including KRAS and PIK3CA in patients with colorectal cancer [87], EGFR in breast cancer patients [88] and in NSCLC patients [88,89]. Here, KRAS is linked to non-small cell lung carcinoma.